Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zoladex
Pharma
AstraZeneca and Alvogen receive wrist slap from Korea's FTC
For copycat drugmaker Alvogen and British Big Pharma AstraZeneca, the cost of allegedly stalling generics to AZ’s Zoladex is just $1.82M in Korea.
Fraiser Kansteiner
Oct 13, 2022 1:40pm
AstraZeneca says $50M U.K. project has no Brexit implications
Aug 30, 2017 9:55am
AZ inks $250M Zoladex deal in latest closet cleanout
Feb 21, 2017 7:39am
